Logo image of CWAN

CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

NYSE:CWAN - New York Stock Exchange, Inc. - US1851231068 - Common Stock - Currency: USD

21.77  -0.12 (-0.55%)

After market: 21.85 +0.08 (+0.37%)

Fundamental Rating

6

Overall CWAN gets a fundamental rating of 6 out of 10. We evaluated CWAN against 282 industry peers in the Software industry. CWAN has an excellent financial health rating, but there are some minor concerns on its profitability. CWAN is valued quite expensive, but it does show an excellent growth. These ratings would make CWAN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CWAN had positive earnings in the past year.
CWAN had a positive operating cash flow in the past year.
In the past 5 years CWAN reported 4 times negative net income.
CWAN had a positive operating cash flow in 4 of the past 5 years.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

With an excellent Return On Assets value of 33.38%, CWAN belongs to the best of the industry, outperforming 98.23% of the companies in the same industry.
CWAN has a better Return On Equity (38.45%) than 93.26% of its industry peers.
With a decent Return On Invested Capital value of 1.28%, CWAN is doing good in the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
ROA 33.38%
ROE 38.45%
ROIC 1.28%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

CWAN has a Profit Margin of 90.13%. This is amongst the best in the industry. CWAN outperforms 98.94% of its industry peers.
CWAN's Profit Margin has improved in the last couple of years.
The Operating Margin of CWAN (4.09%) is better than 70.57% of its industry peers.
CWAN's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 72.95%, CWAN is doing good in the industry, outperforming 60.99% of the companies in the same industry.
CWAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.09%
PM (TTM) 90.13%
GM 72.95%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CWAN is destroying value.
The number of shares outstanding for CWAN has been increased compared to 1 year ago.
CWAN has more shares outstanding than it did 5 years ago.
CWAN has a better debt/assets ratio than last year.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CWAN has an Altman-Z score of 23.00. This indicates that CWAN is financially healthy and has little risk of bankruptcy at the moment.
CWAN has a Altman-Z score of 23.00. This is amongst the best in the industry. CWAN outperforms 95.04% of its industry peers.
The Debt to FCF ratio of CWAN is 0.54, which is an excellent value as it means it would take CWAN, only 0.54 years of fcf income to pay off all of its debts.
CWAN's Debt to FCF ratio of 0.54 is fine compared to the rest of the industry. CWAN outperforms 78.01% of its industry peers.
CWAN has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
CWAN has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: CWAN outperforms 58.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.54
Altman-Z 23
ROIC/WACC0.14
WACC8.91%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

CWAN has a Current Ratio of 5.09. This indicates that CWAN is financially healthy and has no problem in meeting its short term obligations.
CWAN's Current ratio of 5.09 is amongst the best of the industry. CWAN outperforms 88.65% of its industry peers.
A Quick Ratio of 5.09 indicates that CWAN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.09, CWAN belongs to the best of the industry, outperforming 88.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.09
Quick Ratio 5.09
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

10

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.73% over the past year.
The Earnings Per Share has been growing by 110.89% on average over the past years. This is a very strong growth
Looking at the last year, CWAN shows a very strong growth in Revenue. The Revenue has grown by 23.21%.
The Revenue has been growing by 21.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.73%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%30%
Revenue 1Y (TTM)23.21%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%23.51%

3.2 Future

CWAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
Based on estimates for the next years, CWAN will show a very strong growth in Revenue. The Revenue will grow by 27.93% on average per year.
EPS Next Y29.2%
EPS Next 2Y27.24%
EPS Next 3Y16.22%
EPS Next 5Y28.57%
Revenue Next Year62.42%
Revenue Next 2Y45.28%
Revenue Next 3Y35.34%
Revenue Next 5Y27.93%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.35 indicates a quite expensive valuation of CWAN.
Based on the Price/Earnings ratio, CWAN is valued a bit cheaper than 62.06% of the companies in the same industry.
CWAN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.28.
A Price/Forward Earnings ratio of 29.88 indicates a quite expensive valuation of CWAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CWAN indicates a somewhat cheap valuation: CWAN is cheaper than 64.18% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CWAN to the average of the S&P500 Index (21.76), we can say CWAN is valued slightly more expensively.
Industry RankSector Rank
PE 45.35
Fwd PE 29.88
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CWAN's Enterprise Value to EBITDA is on the same level as the industry average.
CWAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 73.86
EV/EBITDA 184.62
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CWAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CWAN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CWAN's earnings are expected to grow with 16.22% in the coming years.
PEG (NY)1.55
PEG (5Y)0.41
EPS Next 2Y27.24%
EPS Next 3Y16.22%

0

5. Dividend

5.1 Amount

CWAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (7/2/2025, 8:04:00 PM)

After market: 21.85 +0.08 (+0.37%)

21.77

-0.12 (-0.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners89.27%
Inst Owner Change5.9%
Ins Owners1.17%
Ins Owner Change42.84%
Market Cap6.17B
Analysts83.33
Price Target34.57 (58.8%)
Short Float %4.43%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.94%
Min EPS beat(2)2.56%
Max EPS beat(2)13.33%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-0.14%
Max EPS beat(4)13.33%
EPS beat(8)7
Avg EPS beat(8)10.35%
EPS beat(12)10
Avg EPS beat(12)9.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.25%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)3.06%
Revenue beat(4)2
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.06%
Revenue beat(8)5
Avg Revenue beat(8)0.24%
Revenue beat(12)7
Avg Revenue beat(12)0.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.93%
PT rev (3m)-6.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.57%
EPS NY rev (1m)-1.51%
EPS NY rev (3m)7.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)35.16%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)34.17%
Valuation
Industry RankSector Rank
PE 45.35
Fwd PE 29.88
P/S 12.96
P/FCF 73.86
P/OCF 69.46
P/B 5.53
P/tB 6.85
EV/EBITDA 184.62
EPS(TTM)0.48
EY2.2%
EPS(NY)0.73
Fwd EY3.35%
FCF(TTM)0.29
FCFY1.35%
OCF(TTM)0.31
OCFY1.44%
SpS1.68
BVpS3.94
TBVpS3.18
PEG (NY)1.55
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA 33.38%
ROE 38.45%
ROCE 1.62%
ROIC 1.28%
ROICexc 1.67%
ROICexgc 2.19%
OM 4.09%
PM (TTM) 90.13%
GM 72.95%
FCFM 17.54%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-67.54%
ROICexcg growth 5Y-60.6%
ROICexc growth 3Y-68.91%
ROICexc growth 5Y-61.61%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.54
Debt/EBITDA 1.32
Cap/Depr 41.39%
Cap/Sales 1.11%
Interest Coverage 5.08
Cash Conversion 275.22%
Profit Quality 19.46%
Current Ratio 5.09
Quick Ratio 5.09
Altman-Z 23
F-Score5
WACC8.91%
ROIC/WACC0.14
Cap/Depr(3y)83.6%
Cap/Depr(5y)112.55%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.73%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%30%
EPS Next Y29.2%
EPS Next 2Y27.24%
EPS Next 3Y16.22%
EPS Next 5Y28.57%
Revenue 1Y (TTM)23.21%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%23.51%
Revenue Next Year62.42%
Revenue Next 2Y45.28%
Revenue Next 3Y35.34%
Revenue Next 5Y27.93%
EBIT growth 1Y283.86%
EBIT growth 3Y-24.56%
EBIT growth 5Y-21.29%
EBIT Next Year70.47%
EBIT Next 3Y42.13%
EBIT Next 5Y36.03%
FCF growth 1Y61.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.4%
OCF growth 3Y180.71%
OCF growth 5YN/A